Publications by authors named "F Correia"

Background: The Montreal classification has been widely used in Crohn's disease since 2005 to categorize patients by the age of onset (A), disease location (L), behavior (B), and upper gastrointestinal tract and perianal involvement. With evolving management paradigms in Crohn's disease, we aimed to assess the performance of gastroenterologists in applying the Montreal classification.

Methods: An online survey was conducted among participants at an international educational conference on inflammatory bowel diseases.

View Article and Find Full Text PDF

Background: Obesity is a known risk factor and aggravator of musculoskeletal (MSK) conditions. The rising prevalence of obesity calls for scalable solutions to address MSK conditions in this population, given their complex clinical profile and barriers to accessing care.

Purpose: To evaluate the engagement and clinical outcomes of a fully remote digital care program in patients with MSK conditions, focusing on those with and without comorbid obesity.

View Article and Find Full Text PDF
Article Synopsis
  • Bluetongue virus serotype 3 (BTV-3) was detected in Portugal's Alentejo region in September 2024, first identified in a sheep showing severe symptoms like head swelling and respiratory issues.
  • Two cases were confirmed within the same area, leading to high mortality rates in affected livestock.
  • In light of the rapid spread of BTV-3, monitoring and vaccination campaigns are underway to protect livestock health and control the virus's transmission.
View Article and Find Full Text PDF

Serotonin syndrome (SS) is a potentially life-threatening condition caused by excessive serotonergic activity, often due to drug interactions. It classically manifests with autonomic and neuromuscular hyperactivity and by mental status changes that might include restlessness, delirium, and agitation. We present a case of a 76-year-old patient with Parkinson's disease with SS triggered by interaction between rasagiline and buspirone.

View Article and Find Full Text PDF

Background: Endoscopic retrograde cholangiopancreatography (ERCP) is the first-line procedure for choledocholithiasis treatment. However, it is associated with a 10 % rate of adverse events. Spontaneous migration of common bile duct (CBD) stones occurs in 6-33 % of choledocholithiasis cases, making ERCP avoidable.

View Article and Find Full Text PDF